Sabra Health Care REIT, Inc.（简称Sabra）近日宣布两项重要人事变动：正式任命达林·史密斯（Darrin Smith）担任首席投资官一职，同时向即将荣休的塔莉亚·内沃-哈科亨（Talya Nevo-Hacohen）致以诚挚祝贺。
这一人事安排标志着Sabra在投资战略部署上的关键调整。史密斯将全面负责公司的投资组合管理、资本配置及并购业务，其深厚的行业经验有望为REIT的资产优化注入新动能。而内沃-哈科亨在任期间对Sabra的资本运作与风险管控体系贡献卓著，其退休过渡计划已有序启动。
此次高管交接体现了Sabra在医疗地产投资领域持续强化专业团队的决心。公司表示，史密斯的上任将加速现有投资策略的落地，同时确保核心业务板块的稳定运营。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.